The prevention and treatment of bacterial infections in children with asplenia or hyposplenia: Practice considerations at the Hospital for Sick Children, Toronto

Pediatric Blood and Cancer

Volumn 46, Issue 5, 2006, Pages 597-603

  Price, Victoria E ^a   Dutta, Sanjeev ^b   Blanchette, Victor S ^a   Butchart, Sheila ^a   Kirby, Melanie ^a   Langer, Jacob C ^a   Ford Jones, E Lee ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

Author keywords

Asplenia; Bacterial infections; Children; Prevention; Treatment

Indexed keywords

AMOXICILLIN; CEFTRIAXONE; CHICKENPOX VACCINE; CLINDAMYCIN; COTRIMOXAZOLE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; INFLUENZA VACCINE; MENINGOCOCCUS VACCINE; PENICILLIN V; PNEUMOCOCCUS VACCINE; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ASPLENIA; BACTERIAL INFECTION; CANADA; CHILD; HOSPITAL PATIENT; HUMAN; IMMUNIZATION; INFECTION RISK; PENICILLIN ALLERGY; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK BENEFIT ANALYSIS; SEPSIS; SPLEEN DISEASE; SPLEEN FUNCTION; SPLENECTOMY; STREPTOCOCCUS INFECTION; VACCINATION;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; BACTERIAL VACCINES; CHILD; CHILD, HOSPITALIZED; HOSPITALS, PEDIATRIC; HUMANS; ONTARIO; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; SPLEEN; SPLENECTOMY; SPLENIC DISEASES; VACCINATION;

EID: 33645283056     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20477     Document Type: Review

References (38)

1. Chesney JA. Asplenia. In: Patrick CC, editor. Clinical management of infections in immunecompromised infants and children. Philadelphia: Lipincott Williams and Wilkins; 2001. p 307-326.
2. Inuma H, Okinaga K, Sato S, et al. Optimal site and amount of splenic tissue for autotransplantation. J Surg Res 1992;53:109-116.
3. Horton J, Ogden ME, Williams S, et al. The importance of splenic blood flow in clearing pneumococcal organisms. Ann Surg 1982;195:172-176.
4. Resende V, Petroianu A. Functions of the splenic remnant after subtotal splenectomy for treatment of severe splenic injuries. Am J Surg 2003;185:311-315.
5. Brigden M, Pattullo AL. Prevention and management of overwhelming postsplenectomy infection: An update. Crit Care Med 1999;27:836-842.
6. Scerpello EG. Functional asplenia and pneumococcal sepsis in patients with systemic lupus erythematosus. Clin Infect Dis 1995;20:194-195.
7. Kahls P, Panzer S, Kletter K, et al. Functional asplenia after bone marrow transplantation. Ann Intern Med 1988;109:461-464.
8. Lynch AM, Kapila R. Overwhelming postsplenectomy infection. Infect Dis Clin North Am 1996;10:693-707.
9. Kimura F, Ito H, Shimizu H, et al. Partial splenic embolizfation for the treatment of hereditary spherocytosis. Am J Roentgenol 2003;181:1021-1024.
10. Khatkouda N, Mavor E. Laparoscopic splenectomy. Surg Clin North Am 2000;80:1285-1297.
11. Alvarez FE, Greco RS. Regeneration of the spleen after ectopic implantation and partial splenectomy. Arch Surg 1980;115:772-775.
12. Hansen K, Singer DB. Asplenic-hyposplenic overwhelming sepsis: Postsplenectomy sepsis revisited. Pediatr Dev Pathol 2001;4:105-121.
13. Sumaraju V, Smith LG, Smith SM. Infectious complications in asplenic hosts. Infect Dis Clin North Am 2001;15:551-565.
14. Lion C, Escande F, Burdin JC. Capnocytophaga canimorsus infections in human: Review of the literature and cases report. Eur J Epidemiol 1996;12:521-533.
15. Rosner F, Zarrabi MH, Benach JL, Habicht GS. Babesiosis in splenectomized adults. Review of 22 reported cases. Am J Med 1984;76:696-701.
16. Singer DB. Postsplenectomy sepsis. Perspect Pediatr Pathol 1973;1:285-311.
17. Holdsworth RJ, Irving AD, Cuschieri A. Post splenectomy sepsis and its mortality rate: Actual versus perceived risks. Br J Surg 1991;78:1031-1034.
18. Davidson RN, Wall RA. Prevention and management of infections in patients without a spleen. Clin Microbiol Infect 2001;7:657-660.
19. American Academy of Pediatrics. Immunocompromised children-Asplenic children. The red book, report of the committee on infectious diseases, 25th edn. Elk Grove Village, IL, USA: American Academy of Pediatrics; 2000.
20. Eber SW, Langendorfer CM, Ditzig M. et al. Frequency of very late fatal sepsis after splenectomy for hereditary spherocytosis: Impact of insufficient antibody response to pneumococcal infection. Ann Hematol 1999;78:524-528.
21. American Academy of Pediatrics. Committee on Infectious Diseases. Policy statement: Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 2000;106:362-366.
22. Klinge J, Hammersen G, Scharf J, et al. Overwhelming postsplenectomy infection with vaccine-type streptococcus pneumoniae in a 12-year-old girl despite vaccination and antibiotic prophylaxis. Infection 1997;25:368-371.
23. Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 1986;314:1593-1599.
24. Jugenburg M, Haddock G, Freedman MH, et al. The morbidity and mortality of pediatric splenectomy: Does prophylaxis make a difference? J Pediatr Surg 1999;34:1064-1067.
25. Fisher Randall G, Boyce Thomas G. Moffet's pediatric infectious diseases-A problem oriented approach. Philadelphia: Lippincott Williams and Wilkins; 2005. p 705-737.
26. Infectious Diseases and Immunization Committee, Canadian Paediatric Society. Prevention and therapy of bacterial infections for children with asplenia or hyposplenia. Paediatr Child Health 1999;4:417-421.
27. British Committee for Standards in Haematology. Davies JM, Barnes R, Milligan D. Working Party of the Haematology/Oncology Task Force. Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Clin Med 2002;2:440-443.
28. Keenan RD, Boswell T, Milligan DW. Do post-splenectomy patients take prophylactic penicillin? Br J Haematol 1999;105:509-510.
29. Woods GM, Jorgensen JH, Waclawiw MA, et al. Influence of penicillin prophylaxis on antimicrobial resistance in nasopharyngeal S. pneumoniae among children with sickle cell anemia. The ancillary nasopharyngeal culture study of prophylactic penicillin study II. J Pediatr Hematol Oncol 1997;19:327-333.
30. Centers for Diseases Control. 2003. Epidemiology and prevention of vaccine preventable diseases. The pink book, 7th ed. http://www.cdc.gov/nip/ publications/pink/
31. Shatz DV, Schinsky MF, Pais LB, et al. Immune responses of splenectomized trauma patients to the 23-valent pneumococcal polysaccharide vaccine at 1 versus 7 versus 14 days after splenectomy. J Trauma 1998;44:760-765.
32. Konradsen HB, Rasmussen C, Ejstrud P, et al. Antibody levels against streptococcus pneumoniae and Haemophilus influenzae type b in a population of splenectomized individuals with varying vaccination status. Epidemiol Infect 1997;119:167-174.
33. Shatz DV, Romero-Steiner S, Elie CM, et al. Antibody responses in postsplenectomy trauma patients receiving the 23-valent pneumococcal polysaccharide vaccine at 14 versus 28 days postoperatively. J Trauma 2002;53:1037-1042.
34. Advisory committee on Immunisation Practices (ACIP). Prevention of pneumococcal disease. MMWR Morb Mortal Wkly Rep 1997;46: (RR8) 1-24.
35. Webber SA, Sandor GG, Patterson MW, et al. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in children with congenital asplenia. J Infect Dis 1993;167:1210-1212.
36. Castagnola E, Floredda F. Prevention of life-threatening infections due to encapsulated bacteria in children with hyposplenia or asplenia: A brief review of current recommendations for practical purposes. Eur J Haematol 2003;71:319-326.
37. Balmer P, Falconer M, McDonald P, et al. Immune response to meningococcal serogroup C conjugate vaccine in asplenic individuals. Infect Immun 2004;72:332-337.
38. Tan B. Varicella (chickenpox). Paediatr Child Health 2004;9:567-568.